Actively Recruiting
Evaluating Cevostamab with Pomalidomide and Dexamethasone Compared to Standard Care in Previously Treated Multiple Myeloma Patients
Led by Hoffmann-La Roche · Updated on 2026-10-13
380
Participants Needed
93
Research Sites
221 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety and effectiveness of a combination treatment including cevostamab, pomalidomide, and dexamethasone compared to the current standard of care in adults with multiple myeloma. Participants have previously received one to three treatments and were exposed to anti-CD38 monoclonal antibodies and lenalidomide, addressing the need for new options after prior therapies. Participants in one group will receive cevostamab intravenously on a 21-day cycle for the first cycle and then every 28 days thereafter, along with oral pomalidomide starting from the second cycle every 28 days. Dexamethasone is given as a premedication before cevostamab. The other group will receive the investigators choice of standard treatment regimens. Both treatments are monitored over an extended period to assess outcomes. Throughout the study, participants will undergo regular evaluations including disease measurements and quality of life assessments using validated questionnaires. Researchers will track responses such as complete remission and progression-free survival for up to five years after enrollment. Safety will be monitored by recording adverse events and treatment tolerability. This long-term follow-up allows comprehensive assessment of treatment impact and participant well-being.
CONDITIONS
Brief Title
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Research Team
R
Reference Study ID Number: CO46096 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here